Survival According to Therapy Regimen for Small Intestinal Neuroendocrine Tumors.

For stage IV patients in this analysis (limited by low patient numbers in co. 3/4), multimodal treatment did not significantly improve survival over SSA treatment alone. A resection of primary tumor significantly improves survival.